Page last updated: 2024-08-23

substance p and celecoxib

substance p has been researched along with celecoxib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salam, OM1
Alves, DL; Caliari, MV; Duarte, ID; Francischi, JN; Maltos, KL; Menezes, GB; Rocha, OA; Santos, JM1
Green, C; Hewlett, E; Hughes, M; Padgett, D; Schwartz, L; Tessier, J; Zhao, W1
Balzarini, P; Bianchi, M; Broggini, M; Franchi, S; Sacerdote, P1
Balla, K; Bendele, A; Bogseth, R; Gass, J; Graham, S; Hutchcraft, A; Rabinow, B; Valaitis, P; Werling, J1
Hiller, JG; Ho, KM; Kuruvilla, N; Millen, R; Ramsay, R; Riedel, B; Sampurno, S1

Trials

2 trial(s) available for substance p and celecoxib

ArticleYear
Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
    International journal of clinical practice, 2007, Volume: 61, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Celecoxib; Double-Blind Method; Female; Humans; Interleukin-6; Interleukin-8; Male; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Substance P; Sulfonamides; Synovial Fluid; Treatment Outcome

2007
Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2017, Volume: 64, Issue:5

    Topics: Aged; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Neoplasms; Pain, Postoperative; Prospective Studies; Substance P

2017

Other Studies

4 other study(ies) available for substance p and celecoxib

ArticleYear
Modulation of inflammatory paw oedema by cysteamine in the rat.
    Pharmacological research, 2002, Volume: 45, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Corticotropin-Releasing Hormone; Cystamine; Edema; Formaldehyde; Histamine; Indomethacin; Pyrazoles; Rats; Somatostatin; Substance P; Sulfonamides; Tumor Necrosis Factor-alpha

2002
Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp.
    Archives of oral biology, 2004, Volume: 49, Issue:6

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Calcitonin Gene-Related Peptide; Capillary Permeability; Celecoxib; Cyclooxygenase Inhibitors; Dental Pulp; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Leukocytes; Lipopolysaccharides; Male; Pulpitis; Pyrazoles; Rats; Skin; Substance P; Sulfonamides

2004
Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis.
    Infection and immunity, 2007, Volume: 75, Issue:4

    Topics: Animals; Antigens, Bacterial; Aprepitant; Bacillus anthracis; Bacterial Toxins; Capillary Permeability; Celecoxib; Cell Degranulation; Cell Line; Disease Models, Animal; Edema; Enzyme Inhibitors; Histamine; Histamine H1 Antagonists; Humans; Indomethacin; Injections, Intradermal; Mast Cells; Morpholines; Neurokinin-1 Receptor Antagonists; Prostaglandin Antagonists; Prostaglandins; Pyrazoles; Pyrilamine; Rabbits; Substance P; Sulfonamides; Tachykinins

2007
Intra-articular (IA) ropivacaine microparticle suspensions reduce pain, inflammation, cytokine, and substance p levels significantly more than oral or IA celecoxib in a rat model of arthritis.
    Inflammation, 2015, Volume: 38, Issue:1

    Topics: Administration, Oral; Amides; Animals; Arthritis, Experimental; Celecoxib; Cytokines; Inflammation; Injections, Intra-Articular; Male; Microspheres; Pain; Rats; Ropivacaine; Substance P

2015